Literature DB >> 31471054

Management of Nonfunctioning Recurrent Pituitary Adenomas.

Christopher J Farrell1, Tomas Garzon-Muvdi2, Judd H Fastenberg3, Gurston G Nyquist3, Mindy R Rabinowitz3, Marc R Rosen3, James J Evans2.   

Abstract

Pituitary adenomas are typically slow-growing benign tumors. However, 50% to 60% of tumors progress following subtotal resection and up to 30% recur after apparent complete resection. Options for treatment of recurrent pituitary adenomas include repeat surgical resection, radiation therapy, and systemic therapies. There is no consensus approach for the management of recurrent pituitary adenomas. This article reviews the natural history of recurrent adenomas and emerging biomarkers predictive of clinical behavior as well as the outcomes associated with the various treatment modalities for these challenging tumors, with an emphasis on the surgical treatment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  KNOSP grade; Pituitary adenomas; Recurrent pituitary tumor; Transsphenoidal surgery

Mesh:

Year:  2019        PMID: 31471054     DOI: 10.1016/j.nec.2019.05.006

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  4 in total

1.  Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis.

Authors:  Mayra Souza Botelho; Ítalo Antunes Franzini; Vania Dos Santos Nunes-Nogueira; Cesar Luiz Boguszewski
Journal:  Pituitary       Date:  2022-07-28       Impact factor: 3.599

2.  Outcome of Endoscopic Transsphenoidal Surgery for Recurrent or Residual Pituitary Adenomas and Comparison to Non-Recurrent or Residual Cohort by Propensity Score Analysis.

Authors:  Xuan Gong; Yang Zhuo; Huichun Yuan; Kui Yang; Chuntao Li; Songshan Feng; Mingyu Zhang; Zhenyan Li; Hongshu Zhou; Zhixiong Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

Review 3.  Clinical relevance of tumor consistency in pituitary adenoma.

Authors:  Alberto Acitores Cancela; Víctor Rodríguez Berrocal; Héctor Pian; Juan Salvador Martínez San Millán; Juan José Díez; Pedro Iglesias
Journal:  Hormones (Athens)       Date:  2021-06-19       Impact factor: 2.885

4.  A Preoperative MRI-Based Radiomics-Clinicopathological Classifier to Predict the Recurrence of Pituitary Macroadenoma Within 5 Years.

Authors:  Yu Zhang; Yuqi Luo; Xin Kong; Tao Wan; Yunling Long; Jun Ma
Journal:  Front Neurol       Date:  2022-01-05       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.